不同剂量氨溴索联合经鼻持续气道正压通气治疗早产儿肺透明膜病的疗效观察
Clinical Focus（2010）
Abstract
天然提取的肺表面活性物质(PS)治疗早产儿肺透明膜病(HMD)效果肯定[1],但价格昂贵,需气管插管给药,临床较难广泛应用,氨溴索较天然提取的PS有明显的价格优势,但起效较慢,疗效有限[2].我院收治HMD 42例,采用氨溴索首剂加倍联合经鼻持续气道正压通气(NCPAP)进行治疗,现报告如下.
MoreAI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined